Called Lunar-Covid, this vaccine which is developed by Duke-NUS Medical School will start clinical trials next week. The trial will last till Oct for about 100 people. This is good news and we certainly hope that we can move towards phase 2 &3 trials before end of the year. When I look back from the future, I will remember what it felt like at this point in time when uncertainty remains all around.
Daily Manna 